Reported malignancies in the “classic” NF1 group included MPNSTs (n = 15), chronic myeloid leukemia (n = 1), rhabdomyosarcoma (n = 1), and breast cancers (n = 2), with some patients developing several malignant or non-malignant tumors. This evidence concerns the gene NF1 and rhabdomyosarcoma.